The global maggot debridement market size is expected to reach USD 19.1 million by 2027, expanding at a CAGR of 9.8%, according to a new report by Grand View Research, Inc. The rising investment in research and development, growing prevalence of chronic diseases, and the increasing number of burn cases are the key driving factors for the market.
In
the recent past, there has been a rise in the number of surgical procedures
across the globe. Rising prevalence of chronic diseases, such as cancer,
diabetes, and autoimmune diseases, is one of the key factors leading to an
increase in the number of surgeries being performed in the country. The
incidence of infectious and non-communicable diseases has increased over the
past few decades.
This
can be attributed to factors such as urbanization, borderline poverty in most
developing states, antimicrobial resistance, and rising prevalence of
food-borne diseases. An unhealthy lifestyle, lack of physical activity, alcohol
abuse, and smoking are some of the major factors contributing to the rising
prevalence of the abovementioned diseases. According to CDC estimates, in 2017,
more than 100.0 million people were living with diabetes in the U.S.
Type
II diabetes is the most common type of diabetes and 90.0% of the affected
population is suffering from type II diabetes. Diabetic foot ulcer, a common
complication of diabetes, typically requires wound debridement and surgical
intervention to prevent foot amputation. Thus, a rising number of chronic
wounds are anticipated to increase the demand for maggot debridement.
Full Research Report On Maggot Debridement Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/maggot-debridement-market
Maggot Debridement
Market Report Highlights
- In terms of revenue, the
biobags segment held the largest market share in 2019 as it is safe to use
and provides result in 14-28 days
- The chronic wounds segment
held the largest market share in 2019 owing to the increasing prevalence
of diabetic foot ulcers and venous leg ulcers across the globe
- The wound care centers segment
is anticipated to witness the fastest growth over the forecast period
owing to the rising awareness regarding these institutions
- In Asia Pacific, the market
is anticipated to witness the fastest growth over the forecast period
owing to the rising number of surgeries and untapped market for maggot
debridement therapy.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/maggot-debridement-market/request/rs1
Maggot Debridement
Market Segmentation
Grand View Research has segmented
the global maggot debridement market on the basis of administration,
application, end-use, and region:
Maggot Debridement
Administration Outlook (Revenue, USD Million, 2016 - 2027)
- Loose Larva
- Biobags
Maggot Debridement
Application Outlook (Revenue, USD Million, 2016 - 2027)
- Chronic Wounds
- Diabetic Foot Ulcer
- Venous Leg Ulcer
- Pressure Ulcer
- Others
- Acute Wounds
- Surgical & Traumatic
Wounds
- Burn Wounds
Maggot Debridement
End-use Outlook (Revenue, USD Million, 2016 - 2027)
- Hospital
- Clinics
- Wound Care Centers
- Others
Maggot Debridement
Regional Outlook (Revenue, USD Million, 2016 - 2027)
- North America
- The U.S.
- Canada
- Europe
- The U.K.
- Germany
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
- Saudi Arabia
List of Key Players
of Maggot Debridement Market
- BioMonde
- Monarch Labs
- Mega Pharma (Pvt) Ltd.
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment